A transmodulation between PLD2 and the oncogenic kinase RET is evident in thyroid cancer cells where PLD2 enhances STAT3 phosphorylation and transcriptional activation that is mediated by RET (Kim et al., 2008). The gene discussed is PLD2; the disease is thyroid gland carcinoma.